{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:26:02Z","timestamp":1787678762256,"version":"build-2784847793"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.thromres.2025.109516","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T22:10:54Z","timestamp":1760998254000},"page":"109516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Assessing the risk of venous thromboembolism in trans masculine persons on gender-affirming hormone therapy: A literature review"],"prefix":"10.1016","volume":"256","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9223-7052","authenticated-orcid":false,"given":"Juliette","family":"Hugueny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"de Ricolfis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola\u00ef","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Chabbert-Buffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarra","family":"Cristofari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.thromres.2025.109516_bb0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1210\/er.2018-00011","article-title":"Endocrinology of transgender medicine","volume":"40","author":"T\u2019Sjoen","year":"2019","journal-title":"Endocr. Rev."},{"issue":"11","key":"10.1016\/j.thromres.2025.109516_bb0010","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an Endocrine Society* clinical practice guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"sup1","key":"10.1016\/j.thromres.2025.109516_bb0015","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","article-title":"Standards of care for the health of transgender and gender diverse people, version 8","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgend Health"},{"issue":"4","key":"10.1016\/j.thromres.2025.109516_bb0020","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jadohealth.2021.10.036","article-title":"Association of gender-affirming hormone therapy with depression, thoughts of suicide, and attempted suicide among transgender and nonbinary youth","volume":"70","author":"Green","year":"2022","journal-title":"J. Adolesc. Health"},{"key":"10.1016\/j.thromres.2025.109516_bb0025","doi-asserted-by":"crossref","DOI":"10.2196\/64017","article-title":"Mental health changes in US transgender adults beginning hormone therapy via telehealth: longitudinal cohort study","volume":"27","author":"Corman","year":"2025","journal-title":"J. Med. Internet Res."},{"issue":"9","key":"10.1016\/j.thromres.2025.109516_bb0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.31919","article-title":"Early access to testosterone therapy in transgender and gender-diverse adults seeking masculinization: a randomized clinical trial","volume":"6","author":"Nolan","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.thromres.2025.109516_bb0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.0978","article-title":"Mental health outcomes in transgender and nonbinary youths receiving gender-affirming care","volume":"5","author":"Tordoff","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.thromres.2025.109516_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261039","article-title":"Access to gender-affirming hormones during adolescence and mental health outcomes among transgender adults. Radix AE. ed","volume":"17","author":"Turban","year":"2022","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.thromres.2025.109516_bb0045","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1210\/jc.2003-030520","article-title":"Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people","volume":"88","author":"Toorians","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.thromres.2025.109516_bb0050","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2025.109516_bb0055","article-title":"Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"364","author":"Vinogradova","year":"2019","journal-title":"BMJ"},{"issue":"7655","key":"10.1016\/j.thromres.2025.109516_bb0060","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bmj.39555.441944.BE","article-title":"Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis","volume":"336","author":"Canonico","year":"2008","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.thromres.2025.109516_bb0065","article-title":"Combined oral contraceptives: venous thrombosis. Cochrane Fertility Regulation Group","volume":"2014","author":"De Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.thromres.2025.109516_bb0070","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/ijlh.13427","article-title":"Assessment of acquired activated protein C resistance with the FibWave and comparison with the ETP-based APC resistance","volume":"43","author":"Evrard","year":"2021","journal-title":"Int J Lab Hematology"},{"issue":"11","key":"10.1016\/j.thromres.2025.109516_bb0075","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1160\/TH16-03-0205","article-title":"Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France","volume":"116","author":"Delluc","year":"2016","journal-title":"Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.thromres.2025.109516_bb0080","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","article-title":"Global burden of thrombosis: epidemiologic aspects","volume":"118","author":"Wendelboe","year":"2016","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.thromres.2025.109516_bb0085","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/j.1538-7836.2005.01415.x","article-title":"Venous thromboembolism: disease burden, outcomes and risk factors","volume":"3","author":"Heit","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.thromres.2025.109516_bb0090","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1160\/TH17-02-0134","article-title":"Incidence of venous thromboembolism in Asian populations: a systematic review","volume":"117","author":"Lee","year":"2017","journal-title":"Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.thromres.2025.109516_bb0095","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1111\/jth.13769","article-title":"Epidemiology of venous thromboembolism in Africa: a systematic review","volume":"15","author":"Danwang","year":"2017","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2025.109516_bb0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1373\/clinchem.2018.288316","article-title":"Venous thrombotic risk in transgender women undergoing estrogen therapy: a systematic review and Metaanalysis","volume":"65","author":"Khan","year":"2019","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.thromres.2025.109516_bb0105","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ajh.24593","article-title":"T hrombotic issues in transgender medicine: a review","volume":"92","author":"Shatzel","year":"2017","journal-title":"American J Hematol"},{"issue":"12","key":"10.1016\/j.thromres.2025.109516_bb0110","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1111\/jsm.12698","article-title":"Effects of three different testosterone formulations in female-to-male transsexual persons","volume":"11","author":"Pelusi","year":"2014","journal-title":"J. Sex. Med."},{"issue":"3","key":"10.1016\/j.thromres.2025.109516_bb0115","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/jth.12484","article-title":"Endogenous sex hormones and risk of venous thromboembolism in women and men","volume":"12","author":"Holmegard","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2025.109516_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261312","article-title":"The effect of transdermal gender-affirming hormone therapy on markers of inflammation and hemostasis. S\u00e1nchez-Rodr\u00edguez MA. ed","volume":"17","author":"Schutte","year":"2022","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.thromres.2025.109516_bb0125","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/jth.15256","article-title":"Effect of gender-affirming hormone use on coagulation profiles in transmen and transwomen","volume":"19","author":"Scheres","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2025.109516_bb0130","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/rth2.12325","article-title":"Hematocrit and incidence of venous thromboembolism","volume":"4","author":"Folsom","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"issue":"12","key":"10.1016\/j.thromres.2025.109516_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018121","article-title":"Cohort profile: study of transition, outcomes and gender (STRONG) to assess health status of transgender people","volume":"7","author":"Quinn","year":"2017","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.thromres.2025.109516_bb0140","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-023549","article-title":"Thrombosis risk in transgender adolescents receiving gender-affirming hormone therapy","volume":"147","author":"Mullins","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/j.thromres.2025.109516_bb0145","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.thromres.2021.09.005","article-title":"Erythrocytosis and thromboembolic events in transgender individuals receiving gender-affirming testosterone","volume":"207","author":"Oakes","year":"2021","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2025.109516_bb0150","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.fertnstert.2008.12.017","article-title":"Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy","volume":"93","author":"Ott","year":"2010","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.thromres.2025.109516_bb0155","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1210\/clinem\/dgad651","article-title":"Erythrocytosis is rare with exogenous testosterone in gender-affirming hormone therapy","volume":"109","author":"Krishnamurthy","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.thromres.2025.109516_bb0160","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-014-0211-5","article-title":"Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis","volume":"12","author":"Borst","year":"2014","journal-title":"BMC Med."},{"issue":"2","key":"10.1016\/j.thromres.2025.109516_bb0165","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/ejendo\/lvad170","article-title":"Cardiovascular disease in transgender people: a systematic review and meta-analysis","volume":"190","author":"Van Zijverden","year":"2024","journal-title":"Eur. J. Endocrinol."},{"issue":"7","key":"10.1016\/j.thromres.2025.109516_bb0170","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jsxm.2021.04.006","article-title":"Risk for venous thromboembolism in transgender patients undergoing cross-sex hormone treatment: a systematic review","volume":"18","author":"Kotamarti","year":"2021","journal-title":"J. Sex. Med."},{"issue":"1","key":"10.1016\/j.thromres.2025.109516_bb0175","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12959-023-00526-y","article-title":"Association between inflammatory biomarkers and venous thromboembolism: a systematic review and meta-analysis","volume":"21","author":"Ding","year":"2023","journal-title":"Thrombosis J"},{"issue":"1","key":"10.1016\/j.thromres.2025.109516_bb0180","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/jth.14343","article-title":"High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor","volume":"17","author":"Rietveld","year":"2019","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2025.109516_bb0185","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jtha.2022.11.012","article-title":"Adipokines and incident venous thromboembolism: the multi-ethnic study of atherosclerosis","volume":"21","author":"Broni","year":"2023","journal-title":"J. Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.thromres.2025.109516_bb0190","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/archinte.162.10.1182","article-title":"Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology","volume":"162","author":"Tsai","year":"2002","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.thromres.2025.109516_bb0195","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/CIRCULATIONAHA.107.709204","article-title":"Cardiovascular risk factors and venous thromboembolism: a Meta-analysis","volume":"117","author":"Ageno","year":"2008","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.thromres.2025.109516_bb0200","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3324\/haematol.2009.017285","article-title":"High hematocrit as a risk factor for venous thrombosis. Cause or innocent bystander?","volume":"95","author":"Schreijer","year":"2010","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.thromres.2025.109516_bb0205","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1051\/medsci\/2022151","article-title":"Hormonoth\u00e9rapies de transition chez les personnes transgenres","volume":"38","author":"Johnson","year":"2022","journal-title":"Med. Sci. (Paris)"},{"issue":"11","key":"10.1016\/j.thromres.2025.109516_bb0210","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1161\/CIRCULATIONAHA.118.038584","article-title":"Occurrence of acute cardiovascular events in transgender individuals receiving hormone therapy: results from a large cohort study","volume":"139","author":"Nota","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.thromres.2025.109516_bb0215","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M17-2785","article-title":"Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study","volume":"169","author":"Getahun","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.thromres.2025.109516_bb0220","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i5968","article-title":"Testosterone treatment and risk of venous thromboembolism: population based case-control study","author":"Martinez","year":"2016","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.thromres.2025.109516_bb0225","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jamainternmed.2019.5135","article-title":"Association of testosterone therapy with risk of venous thromboembolism among men with and without hypogonadism","volume":"180","author":"Walker","year":"2020","journal-title":"JAMA Intern. Med."},{"issue":"4","key":"10.1016\/j.thromres.2025.109516_bb0230","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41569-022-00787-6","article-title":"Epidemiology and prevention of venous thromboembolism","volume":"20","author":"Lutsey","year":"2023","journal-title":"Nat. Rev. Cardiol."}],"updated-by":[{"DOI":"10.1016\/j.thromres.2026.109804","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000}},{"DOI":"10.1016\/j.thromres.2026.109804","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000}}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482500266X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482500266X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:40:10Z","timestamp":1781019610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938482500266X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":46,"alternative-id":["S004938482500266X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109516","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the risk of venous thromboembolism in trans masculine persons on gender-affirming hormone therapy: A literature review","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109516","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109516"}}